{
"NDC": {
"NDCCode": "72205-154-01",
"PackageDescription": "1 VIAL in 1 CARTON (72205-154-01) / 50 mL in 1 VIAL",
"NDC11Code": "72205-0154-01",
"ProductNDC": "72205-154",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Nelarabine",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Nelarabine",
"DosageFormName": "INJECTION",
"RouteName": "INTRAVENOUS",
"StartMarketingDate": "20240913",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA216948",
"LabelerName": "Novadoz Pharmaceuticals LLC",
"SubstanceName": "NELARABINE",
"StrengthNumber": "5",
"StrengthUnit": "mg/mL",
"Pharm_Classes": "Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2024-10-31",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20241022",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}